Home Cart 0 Sign in  
X

[ CAS No. 1631-26-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1631-26-1
Chemical Structure| 1631-26-1
Chemical Structure| 1631-26-1
Structure of 1631-26-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1631-26-1 ]

Related Doc. of [ 1631-26-1 ]

Alternatived Products of [ 1631-26-1 ]

Product Details of [ 1631-26-1 ]

CAS No. :1631-26-1 MDL No. :MFCD00014540
Formula : C11H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :MKRBAPNEJMFMHU-UHFFFAOYSA-N
M.W : 187.20 Pubchem ID :74204
Synonyms :
N-Benzylmaleimide

Calculated chemistry of [ 1631-26-1 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.09
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 55.26
TPSA : 37.38 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.75 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 0.98
Log Po/w (WLOGP) : 0.58
Log Po/w (MLOGP) : 1.54
Log Po/w (SILICOS-IT) : 1.6
Consensus Log Po/w : 1.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.8
Solubility : 2.95 mg/ml ; 0.0157 mol/l
Class : Very soluble
Log S (Ali) : -1.35
Solubility : 8.3 mg/ml ; 0.0443 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.56
Solubility : 0.518 mg/ml ; 0.00277 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.79

Safety of [ 1631-26-1 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P305+P351+P338-P310 UN#:1759
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1631-26-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1631-26-1 ]
  • Downstream synthetic route of [ 1631-26-1 ]

[ 1631-26-1 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 617-48-1 ]
  • [ 100-46-9 ]
  • [ 1631-26-1 ]
  • [ 78027-57-3 ]
Reference: [1] Journal of Chemical Research - Part S, 1999, # 7, p. 420 - 421
[2] Asian Journal of Chemistry, 2013, vol. 25, # 13, p. 7451 - 7456
  • 2
  • [ 108-31-6 ]
  • [ 100-46-9 ]
  • [ 1631-26-1 ]
YieldReaction ConditionsOperation in experiment
38% at 20℃; Reflux General Procedure: Benzylamine (17 mmol) was added dropwise into a solution of maleic anhydride (20 mmol) in AcOH (10 mL) at room temperature and the resulting suspension was stirred at reflux (overnight). Solvent was removed under reduced pressure and the residue was partitioned between CHCl3 (100 mL) and H2O (30 mL). The aqueous phase was extracted (CHCl3; 3 x 50 mL) and the combined organic phase was washed (saturated aqueous sodium bicarbonate (30 mL) and brine (30 mL)) and the organic phase was dried (Na2SO4), taken to dryness and the residue was purified by silica gel column chromatography.
33% at 5 - 25℃; for 16 h; To a stirred solution of furan-2,5-dione (20.0 g, 204.0 mmol) in EtO (500.0 ml) was added dropwise phenylmethanamine (32.8 g, 306.0 mmol) in Et20 (50 ml) at 5—lO °C. The reaction mixture was stirred at room temperature for 16 h. The crystallized acid was filtered and washed with Et20, then added to a mixture of acetic anhydride (40 ml) and CH3COOK (4.0 g). The suspension was heated on a steam bath (70 °C ) for 16 h, dissolved in CH2CI2 (400ml), washed with aq.NaHCO3 (2 x 500 ml) and concentrated. The residue was purified by column chromatography (PE/EtOAc =10/1) to give the desired product as a white solid (12.6 g, yield: 33percent).1H NMR (400 MHz, CDCI3) 7.35—7.28 (m, 5H), 6.70 (s, 2H), 4.67 (s, 2H),
30% With acetic acid In dichloromethane at 120℃; for 4 h; Maleic anhydride (0.98 g, 10 mmol) dissolved in glacial acetic acid (15 ml) in, side electromagnetic stirring and slowly instillment animal pen amine (0.83 g, 6 . 67 mmol), the reaction liquid is heated to 120 °C stirring reflux 4 h. TLC detection reaction has been substantially completely, stop stirring, cooled to the room temperature, for a dilute sodium hydroxide solution prepared (8g/100 ml) diluted in and the reaction solution, ethyl acetate (30 ml × 3) extraction three times, the collection of organic phase, the organic phase dried with anhydrous sodium sulfate 12 h. Filtering, environment friendly with silica gel column chromatography, eluting agent is ethyl acetate: petroleum ether=1:10, to obtain white solid 0.41 g, yield 30.0percent.
29% for 5 h; Reflux To a suspension of cis-butenedioic anhydride (1b) (49 g, 0.5 mol)in 600mL AcOH was added benzylamine (54 g, 0.5 mmol). The reactionwas then heated to reflux for 5 h. The reaction mixture wasconcentrated and the residue was dissolved in 300 mL EtOAc. TheEtOAc layerwaswashed with saturated aqueous NaHCO3 and brine.The organic layer was dried over anhydrous Na2SO4, concentratedin vacuum, purified by flash chromatography (petroleum ether:-EtOAc 8:1) to afford 1-benzyl-1H-pyrrole-2,5-dione as a whitesolid (26.9 g, 29percent). M.p.: 58-60 °C. 1H NMR (400 MHz, CDCl3) d 4.65(s, 2H), 6.68 (s, 2H), 7.24-7.30 (m, 5H); 13C NMR (100 MHz, CDCl3)d 41.4, 127.8, 128.3, 128.7, 134.2, 136.1, 170.4; HRMS (ESI) m/z calcdfor C11H9NO2[MH] 188.0706, found 188.0709.

Reference: [1] Journal of Chemical Research - Part S, 1998, # 5, p. 272 - 273
[2] Journal of the Chinese Chemical Society, 2009, vol. 56, # 4, p. 839 - 842
[3] Synthesis, 2004, # 7, p. 995 - 998
[4] Tetrahedron Letters, 1997, vol. 38, # 46, p. 8089 - 8092
[5] Tetrahedron Asymmetry, 2008, vol. 19, # 18, p. 2115 - 2118
[6] Tetrahedron, 1999, vol. 55, # 37, p. 11365 - 11384
[7] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2005, vol. 44, # 7, p. 1476 - 1480
[8] Synlett, 2009, # 2, p. 297 - 301
[9] Organic and Biomolecular Chemistry, 2013, vol. 11, # 3, p. 407 - 411
[10] Journal of Heterocyclic Chemistry, 2009, vol. 46, # 6, p. 1154 - 1176
[11] Analytical Biochemistry, 2011, vol. 418, # 2, p. 184 - 196
[12] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 10, p. 2986 - 2990
[13] Patent: WO2018/137593, 2018, A1, . Location in patent: Page/Page column 189
[14] Patent: CN108929260, 2018, A, . Location in patent: Paragraph 0109-0111
[15] European Journal of Medicinal Chemistry, 2019, p. 408 - 422
[16] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2876 - 2879
[17] Synthesis, 2011, # 10, p. 1595 - 1598
[18] Beilstein Journal of Organic Chemistry, 2012, vol. 8, p. 192 - 200
[19] Angewandte Chemie - International Edition, 2013, vol. 52, # 8, p. 2203 - 2206[20] Angew. Chem., 2013, vol. 125, p. 2259 - 2262,4
[21] Chemical Communications, 2014, vol. 50, # 88, p. 13506 - 13509
[22] Chemical Communications, 2016, vol. 52, # 12, p. 2493 - 2496
[23] Organic Letters, 2018, vol. 20, # 10, p. 2835 - 2838
  • 3
  • [ 134575-94-3 ]
  • [ 1631-26-1 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2010, vol. 49, # 4, p. 487 - 488
[2] Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, vol. 27, # 1, p. 117 - 124
[3] Patent: WO2008/92168, 2008, A2, . Location in patent: Page/Page column 19-20
[4] Organic Preparations and Procedures International, 2013, vol. 45, # 4, p. 314 - 320
[5] Journal of Organic Chemistry, 2015, vol. 80, # 5, p. 2724 - 2732
[6] Journal of Agricultural and Food Chemistry, 2016, vol. 64, # 24, p. 4876 - 4881
[7] Chemistry - An Asian Journal, 2017, vol. 12, # 18, p. 2393 - 2398
[8] New Journal of Chemistry, 2018, vol. 42, # 9, p. 6880 - 6888
[9] Advanced Synthesis and Catalysis, 2018, vol. 360, # 18, p. 3553 - 3562
  • 4
  • [ 15329-69-8 ]
  • [ 1631-26-1 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 4, p. 569 - 573
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1983, vol. 22, # 10, p. 1070 - 1071
[3] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1986, vol. 25, p. 342 - 344
[4] Farmaco, 1994, vol. 49, # 10, p. 675 - 677
[5] Tetrahedron Asymmetry, 1997, vol. 8, # 1, p. 101 - 107
[6] Journal of Organic Chemistry, 1997, vol. 62, # 8, p. 2652 - 2654
[7] Pharmaceutical Sciences, 1997, vol. 3, # 2, p. 67 - 71
[8] Farmaco, 2002, vol. 57, # 5, p. 421 - 426
[9] Synthesis, 2003, # 10, p. 1549 - 1552
[10] Arzneimittel-Forschung/Drug Research, 2005, vol. 55, # 2, p. 123 - 132
[11] Journal of the Chemical Society. Perkin Transactions 2, 2002, # 9, p. 1611 - 1619
[12] Journal of Organic Chemistry, 1991, vol. 56, # 20, p. 5893 - 5903
[13] Australian Journal of Chemistry, 1991, vol. 44, # 2, p. 323 - 330
[14] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 1, p. 560 - 568
[15] Journal of Medicinal Chemistry, 2009, vol. 52, # 23, p. 7410 - 7420
[16] Organic and Biomolecular Chemistry, 2010, vol. 8, # 19, p. 4444 - 4450
[17] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 9, p. 2823 - 2834
[18] Journal of Chemical Sciences, 2013, vol. 125, # 6, p. 1529 - 1534
[19] Macromolecules, 2016, vol. 49, # 17, p. 6193 - 6202
  • 5
  • [ 541-59-3 ]
  • [ 100-51-6 ]
  • [ 1631-26-1 ]
Reference: [1] Organic Preparations and Procedures International, 2008, vol. 40, # 6, p. 574 - 574
[2] Tetrahedron Letters, 2006, vol. 47, # 15, p. 2619 - 2622
[3] Tetrahedron Letters, 1994, vol. 35, # 5, p. 665 - 668
[4] Journal of Organic Chemistry, 1995, vol. 60, # 16, p. 5352 - 5355
  • 6
  • [ 100-46-9 ]
  • [ 1631-26-1 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 29, p. 3525 - 3528
[2] Journal of Organic Chemistry, 1991, vol. 56, # 20, p. 5893 - 5903
[3] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1983, vol. 22, # 10, p. 1070 - 1071
[4] Gazzetta Chimica Italiana, 1896, vol. 26 I, p. 438
[5] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 9, p. 2823 - 2834
[6] Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, vol. 27, # 1, p. 117 - 124
[7] Organic Preparations and Procedures International, 2013, vol. 45, # 4, p. 314 - 320
[8] Journal of Chemical Sciences, 2013, vol. 125, # 6, p. 1529 - 1534
[9] Journal of Organic Chemistry, 2015, vol. 80, # 5, p. 2724 - 2732
[10] Journal of Agricultural and Food Chemistry, 2016, vol. 64, # 24, p. 4876 - 4881
[11] Chemistry - An Asian Journal, 2017, vol. 12, # 18, p. 2393 - 2398
[12] New Journal of Chemistry, 2018, vol. 42, # 9, p. 6880 - 6888
[13] Journal of Organic Chemistry, 2018, vol. 83, # 8, p. 4427 - 4440
[14] Advanced Synthesis and Catalysis, 2018, vol. 360, # 18, p. 3553 - 3562
  • 7
  • [ 133341-92-1 ]
  • [ 1631-26-1 ]
Reference: [1] Australian Journal of Chemistry, 1991, vol. 44, # 2, p. 323 - 330
  • 8
  • [ 272449-67-9 ]
  • [ 1631-26-1 ]
Reference: [1] Synthetic Communications, 2000, vol. 30, # 8, p. 1379 - 1388
  • 9
  • [ 903758-94-1 ]
  • [ 1631-26-1 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2010, vol. 49, # 4, p. 487 - 488
  • 10
  • [ 932-90-1 ]
  • [ 1631-26-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 3, p. 407 - 411
  • 11
  • [ 100-52-7 ]
  • [ 1631-26-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 3, p. 407 - 411
  • 12
  • [ 85843-33-0 ]
  • [ 2592-95-2 ]
  • [ 1631-26-1 ]
  • [ 135457-83-9 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 20, p. 5893 - 5903
  • 13
  • [ 617-48-1 ]
  • [ 100-46-9 ]
  • [ 1631-26-1 ]
  • [ 78027-57-3 ]
Reference: [1] Journal of Chemical Research - Part S, 1999, # 7, p. 420 - 421
[2] Asian Journal of Chemistry, 2013, vol. 25, # 13, p. 7451 - 7456
  • 14
  • [ 685543-77-5 ]
  • [ 1631-26-1 ]
Reference: [1] Gazzetta Chimica Italiana, 1896, vol. 26 I, p. 438
[2] Gazzetta Chimica Italiana, 1896, vol. 26 I, p. 438
  • 15
  • [ 15329-69-8 ]
  • [ 108-24-7 ]
  • [ 1631-26-1 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 29, p. 3525 - 3528
  • 16
  • [ 1631-26-1 ]
  • [ 50893-53-3 ]
  • [ 7689-50-1 ]
  • [ 86732-22-1 ]
Reference: [1] Patent: US6355641, 2002, B1, . Location in patent: Page column 39
  • 17
  • [ 1631-26-1 ]
  • [ 134575-07-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 11, p. 2773 - 2776
[2] Org. Process Res. Dev., 2011, vol. 15, # 5, p. 1052 - 1062
Same Skeleton Products
Historical Records